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Dollar spot, caused by Sclerotinia homoeocarpa, is one of the most 
widespread and chronic diseases of golf course turfgrass worldwide (Vargas, 1994).  
Cultural practices designed to minimize periods of leaf wetness and ample nitrogen fertility 
can decrease disease severity, but repeat applications of fungicides throughout the growing 
season are required to effectively manage dollar spot on intensively cultivated turfgrass.  
The objective of this research was to assess the impact of fall and/or early spring fungicide 
applications made to asymptomatic turfgrass on the development of dollar spot disease 
severity the following growing season.  Replicated field studies at two locations with both 
contact and systemic fungicides were conducted in the fall and spring.  Both fall and spring 
preventative fungicide treatments significantly delayed the onset of disease and the 
enduring severity of symptoms.  Weather conditions in the fall significantly influenced the 
effectiveness of the treatments.
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 Dollar spot, caused by the fungus Sclerotinia homoeocarpa F.T. Bennett is one of 
the most prevalent and highly managed turfgrass diseases.  More money is spent on the 
management of dollar spot than any other turfgrass disease (3,5,22).  S. homoeocarpa 
infects most warm- and cool-season grasses, primarily affecting highly cultivated 
turfgrasses.  If not managed, dollar spot can cause death of infected plants, resulting in 
thinned areas of the turf and unsightliness (5).  Symptoms are small (2.5-5.0 cm diameter) 
straw-colored or necrotic spots on low-cut golf course turfgrass, but appear larger (15-30 
cm diameter) and more diffuse on high-cut home lawns.  Necrotic lesions on individual 
leaves are small and circular in the beginning but ultimately extend the width of the leaf 
blade, resulting in hourglass-shaped lesions (Figure 1,2,3).    
Dollar spot was originally called small brown patch, Rhizoctonia spp., and 
thought to be caused by a different species of the organism that causes brown patch, 
Rhizoctonia solani Kuhn, L.P. (13,16).  Bennett in England in 1937 (1) further investigated 
the fungus and renamed it in the Group Ascomycetes, Order Pezizales, Family Helotiaceae, 
Subfamily Helotiae, Section Hylaosporae and Genus Sclerotinia.  Bennett chose the genus 
Sclerotinia because of the formation of aggregates of microsclerotia.  Microsclerotia are 
darkened tissues with hard outer and soft inner cells.  Bennett used isolates from Australia, 
The United States and Great Britain in his classification.  All of the isolates he worked with 
showed different pigmentations, conidia and ascospore production and had different growth 
requirements.  Since his studies, many mycologists have questioned the classification of S. 
homoeocarpa due to the lack of sclerotia production but rather the presence of stroma (10, 
11, 12, 17).  The North American isolate has produced apothecial initials in culture, but 
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mature ascospores nor conidia have ever developed (7, 8).  Tests on the immature apothecia 
involving immunological and biochemical studies have also suggested an incorrect naming 
of the fungus (17, 12).  Recent work by Powell and Vargas (18) analyzing the ribosomal 
DNA internal transcribed spacer (ITS) region has suggested the fungus is more closely 
related to the genus Rutstroemia.  There has been no success in isolating the teleomorph of 
the fungus so reclassification is difficult. 
Grown on potato dextrose agar (PDA), S. homoeocarpa produces fluffy 
white mycelia with extensive aerial mycelia, covering a standard petri dish in 3-5 days.  
Two to three weeks after initial growth on medium, be it PDA or millet seed, a sclerotized 
region or stroma, appears at the edges of the container and around the original source of 
innoculm.  This area will continue to expand until the entire surface is covered.  These 
blackened, hardened areas can be surface sterilized and used for long term storage, as well 
as for purification of isolates(1).   
Management of dollar spot on golf courses is most often accomplished through the 
routine use of fungicides. Cultural practices such as nitrogen fertility management, dew and 
guttation water removal, and maintenance of adequate air circulation are also recommended 
practices for minimizing the development of dollar spot, however, fungicide applications 
are required to maintain disease-free turfgrass (5).  Although many fungicides are available, 
three of the most commonly used classes of fungicides are benzimidazoles, dicarboximides 
and sterol inhibitors or demethlyase inhibitors (DMI’s).  Because of the frequent use of 




A method to more effectively manage dollar spot either through cultural practices or 
fungicide efficacy is needed.  A study done in 2001 by P.J. Landschoot et al., (13) looked at 
the non-target effects of pentachloronitrobenzene (PCNB) on putting green turf, and 
produced surprising results in respect to dollar spot incidence.  Included in their study was 
an iprodione and chlorothalonil comparison treatment as well as their control.  In the third 
year of their study, 2000, there was significantly less disease incidence in the spring on the 
fall chlorothalonil and iprodione plots than on the control and PCNB fall and spring applied 
plots.  This study suggests the application of fungicides to asymptomatic turfgrass in the 
fall has an affect on dollar spot disease incidence in the spring.   
The null hypothesis for this experiment is that fungicide applications to 
asymptomatic turfgrass affect dollar spot severity and incidence in the spring.  The goals of 
this study were to (1) observe the affects of spring and fall applications of fungicides to 
asymptomatic turfgrass and to (2) determine if air temperature have an affect on fungicide 
efficacy in these treatments. 
 
MATERIALS AND METHODS  
 Two replicated field trials were completed at Brookside Golf and Country Club and 
The Ohio Turfgrass Foundation Research and Education Center (The OTF Research 
Center).  All fungicides were applied using a CO2 backpack sprayer at 40 PSI and a spray 
volume of 3 gpm using 6503 TeeJet nozzles.  A randomized complete block design was 
used, with 4 replications per location. Plots were a standard 3 by 5 foot size. 
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Study 1.  To determine if fungicide applications made to asymptomatic turfgrass eliminates 
or delays dollar spot disease incidence, fall and spring applications were made.  One third 
of the plots received a Banner MAXX 1.0 oz/1000 ft2  and Daconil Ultrex, 3.2oz/1000ft2  
(Syngenta Professional Products, Greensboro, North Carolina) combination mix every 21 
days in the fall on September 26, October 17, and November 11, 2003.  The second third of 
the plots received one application of the combination mix in the fall.  The second third of 
the plots received no treatment in the fall.  Banner MAXX 1.0 oz/1000 ft2, and Daconil 
Ultrex 3.2oz/1000ft2, were applied to plots in each of the three treatment groups once on 
May 6, 2004.  The remaining plots received no treatment in the spring. 
Study 2.  In order to asses if weather conditions impact fungicide efficacy in preventative 
applications, biweekly applications were made in the spring and fall.  Banner MAXX 1.0 
oz/1000 ft2, Daconil Ultrex 3.2oz/1000ft2, and a combination mix with the same rates were 
applied once every two weeks.  Applications were made on September 26, October 10, 
October 24, November 7, November 21, 2003, and April 9, April 22, May 6 and May 20, 
2004.     
Disease rating.  Visual assessments of the amount of diseased turfgrass within each plot 
were recorded at two week intervals after significant disease pressure was observed.  Dollar 
spot infection centers (DSIC’s), or necrotic spots were quantified in the center 2 by 4 foot 
area of the plots.  A necrotic area of 5cm2 was considered a single spot.  In treatments 
where disease incidence was significantly lower than control treatments, the weather data 
from the dates of those applications was correlated providing the environmental condition 
when the applications were most effective.  Differences in disease incidence among 
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treatments were assessed with a one-way analysis of variance (ANOVA) using PROC 
GLM of SAS.  Differences among treatment means were determined using Fisher’s 




Study A.  At The OTF Research Center and Brookside Golf and Country Club, three 
applications of fungicides in the fall significantly reduced dollar spot disease severity 
compared with the non-treated check.  Single fungicide applications also  significantly 
reduced disease but, not as much as treatments with three applications.   Interestingly, 
spring treatments of Daconil Ultrexx, Banner MAXX and the combination mix on plots 
sprayed three times in the fall did not differ from those sprayed three times in the fall and 
not in the spring (Table 1). 
 All spring applications of Daconil Ultrexx, Banner MAXX and the combination mix 
applied on May 6th, 2004 significantly reduced disease as compared to the non-treated 
control.  At Brookside Golf and Country Club, all three treatments were equally effective at 
reducing disease.  This was not the trend at The OTF Research Center, where disease 
pressure was significantly greater (152 DSIC’s in the non-treated check compared with 38.5 
DSIC’s at Brookside Golf and Country Club).  At The OTF Research Center, Banner 
MAXX and the combination mix treatment in the spring were more effective at reducing 
disease than Daconil Ultrexx (Table 2).  For example, the combination May 6th treatment 
had 0 DSIC’s and Daconil Ultrexx had 41.8 DSIC’s. 
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Study B.  In general, treatments made on October 10, 24, or October 10 and 24, had 
significantly less disease compared to the non-treated check with the exception of Daconil 
Ultrexx at The OTF Research Center on October 10, 2003.  All applications made on 
September 26, November 7, and 21 were ineffective at reducing disease at both locations.   
 The timing of spring treatments did not impact fungicide efficacy.  All spring 
treatments reduced dollar spot disease severity compared to the non-treated control with the 
exception of April 9 and 22, 2003 (early spring), Daconil Ultrexx treatments at The OTF 
Research Center.  Consistent with Study A, disease pressure was less at Brookside Golf and 
Country Club and all spring treatments reduced dollar spot disease severity compared to the 
non-treated control.    
DISCUSSION 
 Non-treated plots had high rates of disease at The OTF Research Ceneter and 
Brookside Golf and Country Club (152, 130, 145 DSIC’s).  All preventative treatments 
applied to asymptomatic turfgrass were effective at reducing dollar spot disease severity 
compared to the non-treated control the following season with the exception of the early 
spring Daconil Ultrexx treatments at The OTF Research Center.  Three applications in the 
fall of Daconil Ultrexx and Banner MAXX combined were as equally effective as 
combined single fall and single spring treatments. 
 All spring applications (except for early spring Daconil Ultrexx at The OTF 
Research Center) reduced disease severity.  At the time these applications were made, the 
turfgrass was actively growing.  Active photosynthesis was occurring, leaf blades were 
extending and mowing was required.  Based on weather data, S. homoeocarpa was most 
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likely in the same growth stage.  Mycellium was pushing out of the over-wintering 
structures and actively invading plant tissue for infection.  At this point in the life cycle of 
the fungus, S. homoeocarpa was susceptible to fungicides and thus decreased disease 
incidence was observed in these treatments.  The early spring treatments catch the pathogen 
as it is beginning to come out of dormancy.  The weather began to warm, and as the 
turfgrass de-winterized, so did the fungus (Figure 4).  With delay in growth due to the early 
fungicide application, the pathogen needs more time to cause disease later in the spring.  
The late spring treatments had expected efficacy duration, 30 days.    
 Further evidence of this phenomenon of extreme vulnerability during the dormancy 
transition stage appears in the fall applications of 2003.  The fall applications in October 
were the only treatments with significantly reduced disease in the spring.  Again, S. 
homoeocarpa probably is entering dormancy coinciding with the host.  Less mycellial 
growth occurs, it no longer causes disease, and the manufacturing of some type of over-
wintering structure (stromata, or dormant mycellium) is underway.  The weather during this 
time is indicative of winteriziation of the turfgrass and S. homoeocarpa (Figure 5).  
Applications made before the dormancy process began were ineffective due to the ability of  
S. homoeocarpa  to recuperate lost growth before extreme cold temperatures began.  
Treatments made after this winterization process did not reduce disease severity in the 
spring, possibly because the pathogen had already stabilized in a dormant state for the 
winter and fungicides had no affect.   
 This hypothesis is supported by Landschoot et al. (14).  Their study involved fall 
applications of fungicides then observation of dollar spot disease severity the following 
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season.  The third year of their study in, 2000, fall chlorothalonil and iprodione applications 
were made during the previously described dormancy inducing weather pattern.  These 
treatments had significantly reduced disease severity the following spring as compared to 
the non-treated control plots.   A decrease in dollar spot incidence the following spring was 
also observed in the fall pentachloronitrobenzene (PCNB) treatments.  The results of the 
PCNB treatments were more easily explained than the chlorothalonil and iprodione 
treatments, as the persistence of PCNB in soil is well documented (23).  This possibly 
continued to affect the pathogen 5 and 6 months later.  PCNB has also been shown to 
inhibit over-wintering structures such as sclerotia in various soil-borne pathogens, and may 
have prevented S. homoeocarpa from over- wintering (8).  Chlorothalonil and iprodione 
however, are not known to interfere with sclerotia formation nor to persist for months in the 
soil. Therefore, weather playing a role in fungicide efficacy in fall applications is a better 
explanation.   
 In this study, one application made during the correct weather period in the fall was 
sufficient to decrease disease incidence, but not to eliminate it.  This approach enables 
better fungicide efficacy during the spring, but does not lessen the number of applications 
made during one year.  More research is needed regarding the biology of S. homoeocarpa .  
How the pathogen over-winters, if there is a dormancy process, what it involves, and at 
what stage the pathogen most vulnerable is much needed information.  Correlation of S. 
homoeocarpa biology and turfgrass dormancy data to the weather will help increase 
fungicide efficacy in all applications. 
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 In this field study a contact and systemic fungicide were used to test the null 
hypothesis.  Work using chemicals with different modes of action and different brand 
names is underway to ascertain if all chemicals are equally effective.  Research to 
determine if a single application of a systemic fungicide is as effective as two applications 
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Dollar spot severity a 
Non-treated  62 a-d 
Banner MAXXb 9-26-2003 57.3 a-e 
Daconil Ultrexxc 9-26-2003 17.2 ab 
Banner MAXX, Daconil Ultrexx d 9-26-2003 40.3 c-h 
Non-treated  60 a-d 
Daconil Ultrexx 10-10-2003 50 b-g 
Banner MAXX 10-10-2003 15 hij 
Banner MAXX, Daconil Ultrexx 10-10, 10-24-2003 2.8 j 
Daconil Ultrexx 10-24-2003 23 f-j 
Banner MAXX 10-24-2003 27 e-j 
Banner MAXX, Daconil Ultrexx 11-7-2003 71.3 abc 
Daconil Ultrexx 11-7-2003 80.3 ab 
Banner MAXX 11-7-2003 64 a-d 
Non-treated  81.8 a 
Daconil Ultrexx 11-21-2003 79 ab 
Banner MAXX 11-21-2003 77.8 ab 
Banner MAXX, Daconil Ultrexx 11-21-2003 82.5 a 
Daconil Ultrexx 4-9-2004 39 d-i 
Banner MAXX 4-9-2004 8.8 ij 
Banner MAXX, Daconil Ultrexx 4-9-2004 .3 j 
Daconil Ultrexx 4-22-2004 60.5 a-d 
Banner MAXX 4-22-2004 6.5 j 
Banner MAXX, Daconil Ultrexx 4-22-2004 .5 j 
Banner MAXX 5-20-2004 3 j 
Daconil Ultrexx 5-20-2004 4.3 j 
Banner MAXX, Daconil Ultrexx 5-20-2004 .8 j 
Daconil Ultrexx 5-20-2004 4.8 j 
Banner MAXX 5-20-2004 5.3 j 
Banner MAXX, Daconil Ultrexx 5-20-2004 1.3j 
Non-treated  53.3 a-f 
Non-treated  65.5 a-d 
Banner MAXX, Daconil Ultrexx 5-6-2004 0 j 
Daconil Ultrexx 5-6-2004 20.5 g-j 
Banner MAXX 5-6-2004 .5 j 
Table 3.  Disease severity at The OTF Research Center on 6-5-2004, Study 2. 
a Number of dollar spot infection centers (DSIC’s) in the 2 by 4 foot center portion of each plot.    
b Propiconazole, Banner MAXX, 1.0 oz/1000 ft2 
 c Chlorothalonil, Daconil Ultrexx, 3.2 oz/1000 ft2 















Non-treated  40.5 a-d  
Banner MAXb 9-26-2003 13.3 e-h 
 
Daconil Ultrexxc 9-26-2003 17.8 d-h 
Banner MAXX, Daconil Ultrexx d 9-26-2003 19 d-h 
Non-treated  11.5 g-h 
Daconil Ultrexx 10-10-2003 14.8 e-h 
Banner MAXX 10-10-2003 13.8 e-h 
Banner MAXX, Daconil Ultrexx 10-10, 10-24-2003 6 gh 
Daconil Ultrexx 10-24-2003 12.5 fgh 
Banner MAXX 10-24-2003 18 d-h 
Banner MAXX, Daconil Ultrexx 11-7-2003 23 c-h 
Daconil Ultrexx 11-7-2003 55.3 a 
Banner MAXX 11-7-2003 21.3 c-h 
Non-treated  50 ab 
Daconil Ultrexx 11-21-2003 35.8 a-f 
Banner MAXX 11-21-2003 15.5 e-h 
Banner MAXX, Daconil Ultrexx 11-21-2003 44.8 abc 
Daconil Ultrexx 4-9-2004 21.8 c-h 
Banner MAXX 4-9-2004 21.5 c-h 
Banner MAXX, Daconil Ultrexx 4-9-2004 12.5 fgh 
Daconil Ultrexx 4-22-2004 5.8 gh 
Banner MAXX 4-22-2004 4.8 gh 
Banner MAXX, Daconil Ultrexx 4-22-2004 1.3 h 
Banner MAXX 5-20-2004 16.5 d-h 
Daconil Ultrexx 5-20-2004 6.5 gh 
Banner MAXX, Daconil Ultrexx 5-20-2004 3 h 
Daconil Ultrexx 5-20-2004 8.5 gh 
Banner MAXX 5-20-2004 3.3 h 
Banner MAXX, Daconil Ultrexx 5-20-2004 .8 h 
Non-treated  28.8 b-g 
Non-treated  36.8 a-e 
Banner MAXX 
Daconil Ultrexx 
5-6-2004 0 h 
Daconil Ultrexx 5-6-2004 9.8 gh 
Banner MAXX 5-6-2004 3 h 
a Number of dollar spot infection centers (DSIC’s) in the 2 by 4 foot center portion of each plot.    
b Propiconazole, Banner MAXX, 1.0 oz/1000 ft2 
 c Chlorothalonil, Daconil Ultrexx, 3.2 oz/1000 ft2 
d Banner MAXX, 1.0 oz/1000 ft2, Daconil Ultrexx, 3.2 oz/1000 ft2   
Table 4.  Disease severity at Brookside Golf and Country Club on 6-5-2004, Study 2. 
 16
 
Treatment Date of  
application 
Treatment Date of 
application 
Dollar spot 
severity a  
Non-treated    152.5 a 
Banner MAXXb 5/6/2004   2 d 
Non-treated    130.25 a 
Daconil Ultrexc 5/6/2004   41.75 c 
Non-treated    145.75 a 
Banner MAXX 
Daconil Ultrex d 
5/6/2004   0 d 


























Banner MAXX  
Daconil Ultrex 





None  Banner MAXX 
Daconil Ultrex 
9/26/2003 86 b 
Banner MAXX 5/6/2004 Banner MAXX 
Daconil Ultrex 
9/26/2003 1.25 d 
None  Banner MAXX  
Daconil Ultrex 
9/26/2003 97.5 b 
Daconil Ultrex  5/6/2004 Banner MAXX  
Daconil Ultrex 
9/26/2003 10.75 cd 
None  Banner MAXX  
Daconil Ultrex 
9/26/2003 91 b 
Banner MAXX 
Daconil Ultrex 
5/6/2004 Banner MAXX  
Daconil Ultrex 




Table 4.  Dollar spot disease incidence at location B. 
 
a Number of dollar spot infection centers (DSIC’s) in the 2 by 4 foot center portion of each plot.    
b Propiconazole, Banner MAXX, 1.0 oz/1000 ft2 
 c Chlorothalonil, Daconil Ultrexx, 3.2 oz/1000 ft2 
d Banner MAXX, 1.0 oz/1000 ft2, Daconil Ultrexx, 3.2 oz/1000 ft2   
 













Treatment Date of  
application 




Non-treated    38.5 ab 
Banner MAXXb 5/6/2004   19.5 cde 
Non-treated    31.75 bc 
Daconil Ultrexc 5/6/2004   6 ef 
Non-treated    32.75 bc 
Banner MAXX 
Daconil Ultrex d 
5/6/2004   7.5 ef 

























Banner MAXX  
Daconil Ultrex 





None  Banner MAXX 
Daconil Ultrex 
9/26/2003 53.5 a 
Banner MAXX 5/6/2004 Banner MAXX 
Daconil Ultrex 
9/26/2003 7 ef 
None  Banner MAXX  
Daconil Ultrex 
9/26/2003 37.75 ab 
Daconil Ultrex  5/6/2004 Banner MAXX  
Daconil Ultrex 
9/26/2003 16.75 cdef 
None  Banner MAXX  
Daconil Ultrex 
9/26/2003 25.75 bcd 
Banner MAXX 
Daconil Ultrex 
5/6/2004 Banner MAXX  
Daconil Ultrex 
9/26/2003 14.25 def 
Table 2.  Disease severity at Brookside Golf and Country Club on 6-5-2004, Study 1.  
a Number of dollar spot infection centers (DSIC’s) in the 2 by 4 foot center portion of each plot.    
b Propiconazole, Banner MAXX, 1.0 oz/1000 ft2 
c Chlorothalonil, Daconil Ultrexx, 3.2 oz/1000 ft2 









Figure 1.  Dollar spot lesion 
Figure 2.  Dollar spot infection 
centers (DSIC’s) 
































































Figure 5.  Mean daily high and low temperatures in Columbus, Ohio (April-May 
2003). 
